{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:31:00Z","timestamp":1787243460348,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lfs.2022.121121","type":"journal-article","created":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T19:06:59Z","timestamp":1666552019000},"page":"121121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PA","title":["Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria"],"prefix":"10.1016","volume":"311","author":[{"given":"Priya","family":"Godara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajshree","family":"Meghwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varshita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaneswar","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.121121_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CMR.13.3.439","article-title":"Molecular aspects of severe malaria","volume":"13","author":"Chen","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.lfs.2022.121121_bb0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/IAI.01233-13","article-title":"Rosetting plasmodium falciparum-infected erythrocytes bind to human brain microvascular endothelial cells in vitro, demonstrating a dual adhesion phenotype mediated by distinct P. falciparum erythrocyte membrane protein 1 domains","volume":"82","author":"Adams","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2022.121121_bb0015","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/cmi.12479","article-title":"Diverse functional outcomes of Plasmodium falciparum ligation of EPCR: potential implications for malarial pathogenesis","volume":"17","author":"Gillrie","year":"2015","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.lfs.2022.121121_bb0020","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jiu589","article-title":"High-throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes","volume":"211","author":"Gullingsrud","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121121_bb0025","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1038\/s41467-020-19386-5","article-title":"A universal dual mechanism immunotherapy for the treatment of influenza virus infections","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2022.121121_bb0030","first-page":"7","article-title":"Interaction between endothelial protein C receptor and intercellular adhesion molecule 1 to mediate binding of plasmodium falciparum-infected erythrocytes to endothelial cells","author":"Avril","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.lfs.2022.121121_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.chom.2017.02.009","article-title":"Structure-guided identification of a family of dual receptor-binding PfEMP1 that is associated with cerebral malaria","volume":"21","author":"Lennartz","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2022.121121_bb0040","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/infdis\/jix230","article-title":"Parasites causing cerebral falciparum malaria bind multiple endothelial receptors and express EPCR and ICAM-1-binding PfEMP1","volume":"215","author":"Tuikue Ndam","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2022.121121_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination","volume":"4","author":"Bradt","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.lfs.2022.121121_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/mic.0.049601-0","article-title":"Pre-existing immunity against vaccine vectors\u2013friend or foe?","volume":"159","author":"Saxena","year":"2013","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.lfs.2022.121121_bb0055","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.lfs.2022.121121_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay108","article-title":"Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers","volume":"25","author":"Lindsey","year":"2018","journal-title":"J. Travel Med."},{"key":"10.1016\/j.lfs.2022.121121_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.121121_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.jmedchem.0c01530","article-title":"Peptide-drug conjugates with different linkers for cancer therapy","volume":"64","author":"Alas","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0075","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.2174\/1568026618666180118153502","article-title":"ADME and safety aspects of non-cleavable linkers in drug discovery and development","volume":"17","author":"Walles","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045152","article-title":"SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity","volume":"7","author":"Yao","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2022.121121_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.lfs.2022.121121_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PloS one"},{"issue":"Suppl 6","key":"10.1016\/j.lfs.2022.121121_bb0095","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","article-title":"AllerTOP\u2013a server for in silico prediction of allergens","volume":"14","author":"Dimitrov","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.lfs.2022.121121_bb0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.lfs.2022.121121_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.6026\/97320630010221","article-title":"Molecular designing and in silico evaluation of darunavir derivatives as anticancer agents","volume":"10","author":"Mahto","year":"2014","journal-title":"Bioinformation"},{"key":"10.1016\/j.lfs.2022.121121_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.lfs.2022.121121_bb0115","doi-asserted-by":"crossref","first-page":"20124","DOI":"10.1073\/pnas.1911900116","article-title":"Structural insights into diverse modes of ICAM-1 binding by <i>Plasmodium falciparum<\/i>-infected erythrocytes","volume":"116","author":"Lennartz","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2022.121121_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.lfs.2022.121121_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New method for fast and accurate binding-site identification and analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.lfs.2022.121121_bb0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.sjbs.2020.10.023","article-title":"In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches","volume":"28","author":"Sahayarayan","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.lfs.2022.121121_bb0135","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.05.184","article-title":"High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment","volume":"160","author":"Naik","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2022.121121_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the role of the crystal environment in determining protein side-chain conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2022.121121_bb0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.lfs.2022.121121_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.lfs.2022.121121_bb0160","article-title":"High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases","author":"Singh","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.lfs.2022.121121_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13205-022-03304-1","article-title":"Exploring actinomycetes natural products to identify potential multi-target inhibitors against Leishmania donovani","volume":"12","author":"Singh","year":"2022","journal-title":"3 Biotech."},{"key":"10.1016\/j.lfs.2022.121121_bb0170","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.lfs.2022.121121_bb0175","doi-asserted-by":"crossref","first-page":"10688","DOI":"10.1038\/s41598-019-47063-1","article-title":"Molecular dynamics study of the changes in conformation of calmodulin with calcium binding and\/or target recognition","volume":"9","author":"Kawasaki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121121_bb0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc5005262","article-title":"Long-term stabilization of maleimide-thiol conjugates","volume":"26","author":"Fontaine","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0185","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nbt.2968","article-title":"Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates","volume":"32","author":"Lyon","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2022.121121_bb0190","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3762\/bjoc.14.64","article-title":"Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery","volume":"14","author":"Schuster","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0195","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/bc500357n","article-title":"Mild method for succinimide hydrolysis on ADCs: impact on ADC potency, stability, exposure, and efficacy","volume":"25","author":"Tumey","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0200","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-14-S6-S4","article-title":"AllerTOP - a server for in silico prediction of allergens","volume":"14","author":"Dimitrov","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.lfs.2022.121121_bb0205","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/protein\/4.2.155","article-title":"Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence","volume":"4","author":"Guruprasad","year":"1990","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.lfs.2022.121121_bb0210","first-page":"1895","article-title":"Thermostability and aliphatic index of globular proteins","volume":"88","author":"Ikai","year":"1980","journal-title":"J. Biochem."},{"key":"10.1016\/j.lfs.2022.121121_bb0215","first-page":"7","article-title":"Local and global influences on protein turnover in neurons and glia","author":"D\u00f6rrbaum","year":"2018","journal-title":"elife"},{"key":"10.1016\/j.lfs.2022.121121_bb0220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/bioinformatics\/btv674","article-title":"Accurate estimation of isoelectric point of protein and peptide based on amino acid sequences","volume":"32","author":"Audain","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.lfs.2022.121121_bb0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2022.121121_bb0230","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0235","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/bcp.12468","article-title":"Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches","volume":"78","author":"Beaumont","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121121_bb0240","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/mol.110.066746","article-title":"Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and \u03b2-arrestin2 with antinociceptive activity","volume":"78","author":"Zhao","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121121_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/np070114p","article-title":"Diarylheptanoids and a monoterpenoid from the rhizomes of Zingiber officinale: antioxidant and cytoprotective properties","volume":"71","author":"Tao","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2022.121121_bb0250","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/np50053a037","article-title":"Anticandidal activity of eupolauridine and onychine, alkaloids from Cleistopholis patens","volume":"50","author":"Hufford","year":"1987","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2022.121121_bb0255","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1021\/np200093n","article-title":"Isolation and synthesis of antiproliferative eupolauridine alkaloids of Ambavia gerrardii from the Madagascar Dry Forest","volume":"74","author":"Pan","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2022.121121_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248553","article-title":"A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing","volume":"16","author":"Anand","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.lfs.2022.121121_bb0265","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s13205-022-03258-4","article-title":"Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach","volume":"12","author":"Singh","year":"2022","journal-title":"3 Biotech."},{"key":"10.1016\/j.lfs.2022.121121_bb0270","doi-asserted-by":"crossref","first-page":"34984","DOI":"10.1038\/srep34984","article-title":"Structural insights into conformational stability of both wild-type and mutant EZH2 receptor","volume":"6","author":"Aier","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121121_bb0275","article-title":"Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications","volume":"1\u201325","author":"Naik","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.lfs.2022.121121_bb0280","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1021\/bi400575k","article-title":"Influence of N-myristylation and ligand binding on the flexibility of the catalytic subunit of protein kinase A","volume":"52","author":"Bastidas","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2022.121121_bb0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.procs.2019.08.181","article-title":"Structure of biomolecules through molecular dynamics simulations","volume":"156","author":"Arnittali","year":"2019","journal-title":"Procedia Comput. Sci."},{"key":"10.1016\/j.lfs.2022.121121_bb0290","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration is indicator of compactness of protein structure","volume":"42","author":"Lobanov","year":"2008","journal-title":"Mol. Biol."},{"key":"10.1016\/j.lfs.2022.121121_bb0295","doi-asserted-by":"crossref","first-page":"44651","DOI":"10.1038\/srep44651","article-title":"Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121121_bb0300","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2016.06.015","article-title":"Peptide\u2013drug conjugates as effective prodrug strategies for targeted delivery","volume":"110\u2013111","author":"Wang","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2022.121121_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104987","article-title":"Asymptomatic malaria infection prevailing risks for human health and malaria elimination","volume":"93","author":"Prusty","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.lfs.2022.121121_bb0310","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS, S\/AS01 vaccine (Mosquirix\u2122): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2022.121121_bb0315","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/imr.12807","article-title":"Cerebral Plasmodium falciparum malaria: the role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it","volume":"293","author":"Jensen","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2022.121121_bb0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainresbull.2019.01.010","article-title":"Cerebral malaria","volume":"145","author":"Luzolo","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.lfs.2022.121121_bb0325","doi-asserted-by":"crossref","first-page":"D1217","DOI":"10.1093\/nar\/gkx1026","article-title":"NPASS: natural product activity and species source database for natural product research, discovery and tool development","volume":"46","author":"Zeng","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2022.121121_bb0330","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1038\/s41598-018-26318-3","article-title":"Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation","volume":"8","author":"Ma","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121121_bb0335","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/acs.jcim.9b00933","article-title":"Identification of Zika virus NS2B-NS3 protease inhibitors by structure-based virtual screening and drug repurposing approaches","volume":"60","author":"Santos","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.lfs.2022.121121_bb0340","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejmech.2018.11.062","article-title":"Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening","volume":"163","author":"Melo-Filho","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0345","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S0031182020000207","article-title":"Computational approaches for drug discovery against trypanosomatid-caused diseases","volume":"147","author":"Pereira","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.lfs.2022.121121_bb0350","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/07391102.2020.1712258","article-title":"Structure-based virtual screening, free energy of binding and molecular dynamics simulations to propose novel inhibitors of Mtb-MurB oxidoreductase enzyme","volume":"39","author":"Nirwan","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.lfs.2022.121121_bb0355","doi-asserted-by":"crossref","first-page":"10245","DOI":"10.1039\/C7OB00910K","article-title":"New active leads for tuberculosis booster drugs by structure-based drug discovery","volume":"15","author":"Tatum","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0360","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1021\/acs.jmedchem.0c01624","article-title":"Structure-activity relationship studies of coumarin-like diacid derivatives as human G protein-coupled receptor-35 (hGPR35) agonists and a consequent new design principle","volume":"64","author":"Wei","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0365","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1582-4934.2009.00897.x","article-title":"Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems","volume":"14","author":"L\u00fc","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2022.121121_bb0370","doi-asserted-by":"crossref","first-page":"27986","DOI":"10.1039\/C4RA13315C","article-title":"Free radicals, natural antioxidants, and their reaction mechanisms","volume":"5","author":"Nimse","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.lfs.2022.121121_bb0375","series-title":"Antioxidants","article-title":"Antioxidant compounds and their antioxidant mechanism","author":"Norma Francenia","year":"2019"},{"key":"10.1016\/j.lfs.2022.121121_bb0380","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.niox.2019.05.002","article-title":"NADPH oxidase is a primary target for antioxidant effects by inorganic nitrite in lipopolysaccharide-induced oxidative stress in mice and in macrophage cells","volume":"89","author":"Sui","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.lfs.2022.121121_bb0385","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5794350","article-title":"Natural products for cancer therapy: a review of their mechanism of actions and toxicity in the past decade","volume":"2022","author":"Ali Abdalla","year":"2022","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.lfs.2022.121121_bb0390","article-title":"Peptide\u2013drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?","author":"Fu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2022.121121_bb0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/C9MD00458K","article-title":"Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents","volume":"11","author":"Malik","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.crgsc.2021.100064","article-title":"Click triazole as a linker for drug repurposing against SARs-CoV-2: a greener approach in race to find COVID-19 therapeutic","volume":"4","author":"Chatterjee","year":"2021","journal-title":"Curr. Res. Green Sustain. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0405","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tibtech.2009.07.009","article-title":"Therapeutic application of peptides and proteins: parenteral forever?","volume":"27","author":"Antosova","year":"2009","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.lfs.2022.121121_bb0410","first-page":"1","article-title":"Peptides as drug candidates: limitations and recent development perspectives","author":"Haggag","year":"2018","journal-title":"Biomed. J."},{"key":"10.1016\/j.lfs.2022.121121_bb0415","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopha.2018.04.025","article-title":"Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases","volume":"103","author":"Baig","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2022.121121_bb0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4149\/av_2011_01_61","article-title":"Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein","volume":"55","author":"Stanekov\u00e1","year":"2011","journal-title":"Acta Virol."},{"key":"10.1016\/j.lfs.2022.121121_bb0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40290-018-0261-7","article-title":"Peptide-based therapeutics for oncology","volume":"33","author":"Fisher","year":"2019","journal-title":"Pharm. Med."},{"key":"10.1016\/j.lfs.2022.121121_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00392","article-title":"Peptide immunotherapy for type 1 diabetes\u2014clinical advances","volume":"9","author":"Smith","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121121_bb0435","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(19)31774-X","article-title":"Antibody-drug conjugates for cancer","volume":"394","author":"Chau","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2022.121121_bb0440","article-title":"Peptide conjugates with small molecules designed to enhance efficacy and safety","volume":"24","author":"He","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2022.121121_bb0445","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3762\/bjoc.14.80","article-title":"On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site","volume":"14","author":"Vrettos","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.lfs.2022.121121_bb0450","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/jamaoncol.2019.3552","article-title":"Antibody drug conjugates for cancer treatment","volume":"5","author":"Walko","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lfs.2022.121121_bb0455","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2016.06.015","article-title":"Peptide-drug conjugates as effective prodrug strategies for targeted delivery","volume":"110\u2013111","author":"Wang","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.lfs.2022.121121_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26196042","article-title":"Progress and future directions with peptide-drug conjugates for targeted cancer therapy","volume":"26","author":"Lindberg","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2022.121121_bb0465","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1038\/s41467-020-19386-5","article-title":"A universal dual mechanism immunotherapy for the treatment of influenza virus infections","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"issue":"571","key":"10.1016\/j.lfs.2022.121121_bb9000","article-title":"Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies","volume":"8","author":"Hoppenz","year":"2020","journal-title":"Front. Chem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:02:55Z","timestamp":1758402175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522008219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":94,"alternative-id":["S0024320522008219"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121121","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121121"}}